Method of producing a thymic microenvironment that supports the development of dendritic cells
CA 2268284 A1 · Owner: Haynes, Barton F. · Inventors: Haynes, Barton F.; Smith, Clayton A.; Patel, Dhavalkumar D.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates, in general to thymic microenvironment and, in , particular to a method of producing a thymic microenvironment. The invention further relates to a method of treating congenital and acquired immunodeficiencies using a thymic microenvironment produced in vitro. Included in acquired immunodeficiencies are syndromes seen in malignant and autoimmune diseases as well as traditional T cell immunodeficiency diseases such as occurs in AIDS.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 10, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 10, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 10, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.